← All organizations
Highest phase reached
Phase 3
First clinical trial
May 4, 2017Last known activity
Aug 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (23 distinct, 15 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT07132242CollaboratorPhase 2Aug 30, 2025
- NCT07154316CollaboratorPhase 2Aug 1, 2025
- NCT06715020CollaboratorN/ADec 31, 2024
- NCT06718335Lead sponsorN/ADec 30, 2024
- NCT06718335Sponsor investigatorN/ADec 30, 2024
- NCT06367075CollaboratorPhase 2May 1, 2024
- NCT06333821OfficialPhase 3Apr 1, 2024
- NCT06014190Overall official - principal investigatorPhase 2Dec 31, 2023
- NCT06239870Lead sponsorPhase 2Apr 1, 2023
- NCT05955391CollaboratorPhase 2Jan 18, 2023
- NCT06417476CollaboratorPhase 2Dec 12, 2022
- NCT05340270CollaboratorPhase 2Aug 1, 2022
- NCT04841811Overall official - principal investigatorPhase 2Aug 15, 2021
- NCT05236621OfficialPhase 3Jan 4, 2021
- NCT05236621Overall official - principal investigatorPhase 3Jan 4, 2021
Details
- Last known activity
- Aug 30, 2025